FI924215A0 - Anvaendningen av il-4 foer oekning av immunreaktionen foerorsakad infektiosa antigen aemnen. - Google Patents

Anvaendningen av il-4 foer oekning av immunreaktionen foerorsakad infektiosa antigen aemnen.

Info

Publication number
FI924215A0
FI924215A0 FI924215A FI924215A FI924215A0 FI 924215 A0 FI924215 A0 FI 924215A0 FI 924215 A FI924215 A FI 924215A FI 924215 A FI924215 A FI 924215A FI 924215 A0 FI924215 A0 FI 924215A0
Authority
FI
Finland
Prior art keywords
agents
aemnen
infections
antigen
conduct
Prior art date
Application number
FI924215A
Other languages
English (en)
Other versions
FI924215A (fi
Inventor
Jerome Schwartz
Claude H Nash
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI924215A0 publication Critical patent/FI924215A0/fi
Publication of FI924215A publication Critical patent/FI924215A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FI924215A 1990-03-21 1992-09-21 Anvaendningen av il-4 foer oekning av immunreaktionen foerorsakad infektiosa antigen aemnen FI924215A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49683290A 1990-03-21 1990-03-21
PCT/US1991/001733 WO1991014450A1 (en) 1990-03-21 1991-03-19 Use of il-4 to enhance immune response to infectious antigenic challenges

Publications (2)

Publication Number Publication Date
FI924215A0 true FI924215A0 (fi) 1992-09-21
FI924215A FI924215A (fi) 1992-09-21

Family

ID=23974340

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924215A FI924215A (fi) 1990-03-21 1992-09-21 Anvaendningen av il-4 foer oekning av immunreaktionen foerorsakad infektiosa antigen aemnen

Country Status (19)

Country Link
EP (1) EP0521916B1 (fi)
JP (1) JPH05505799A (fi)
CN (1) CN1055116A (fi)
AT (1) ATE133074T1 (fi)
AU (1) AU656889B2 (fi)
CA (1) CA2078676A1 (fi)
DE (1) DE69116552T2 (fi)
DK (1) DK0521916T3 (fi)
ES (1) ES2082201T3 (fi)
FI (1) FI924215A (fi)
GR (1) GR3019018T3 (fi)
HU (1) HUT63062A (fi)
IE (1) IE72204B1 (fi)
IL (1) IL97600A0 (fi)
MY (1) MY108672A (fi)
OA (1) OA09672A (fi)
PT (1) PT97082B (fi)
WO (1) WO1991014450A1 (fi)
ZA (1) ZA912037B (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100191223B1 (ko) * 1989-07-28 1999-06-15 둘락 노먼 씨. 인터루킨-4의 정제방법 및 이를 함유하는 약제학적 조성물
US5827670A (en) * 1990-08-02 1998-10-27 Fred Hutchinson Cancer Research Center Methods of isolating and detecting bone marrow stromal cells with VCAM-1-specific antibodies
US7449186B1 (en) * 1990-08-02 2008-11-11 Fred Hutchinson Cancer Research Center Methods of blocking the interaction between stromal cells and hemopoietic cells with anti-VCAM-1 antibodies
AU9161591A (en) * 1990-12-19 1992-07-22 Schering Corporation Use of il-4 to enhance immune response to immunogens in vaccines
EP0566661B1 (en) * 1991-01-10 1996-03-13 Schering Corporation Use of il-4 to enhance the reparative phase of wound healing and repair and to enhance the healing of infected wounds and the wounds of diabetic mammals
GB9124347D0 (en) * 1991-11-15 1992-01-08 Isis Innovation Treatment of macrophages
CA2142862C (en) * 1992-08-19 2000-05-30 Jerome Schwartz Method for inhibiting hiv replication using il-4

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT83761B (pt) * 1985-11-19 1989-06-30 Schering Biotech Corp Metodo para a producao de interleuquina-4 de mamifero
ES2059453T3 (es) * 1987-08-03 1994-11-16 Tasuku Honjo Un procedimiento para la produccion de interleuquina 4 humana.
JPH0236129A (ja) * 1988-07-22 1990-02-06 Ajinomoto Co Inc ワクチン効果増強剤
JPH0611706B2 (ja) * 1989-01-20 1994-02-16 ザ ユニバーシティ オブ メルボルン フィブリン溶解

Also Published As

Publication number Publication date
AU656889B2 (en) 1995-02-23
PT97082A (pt) 1991-11-29
EP0521916A1 (en) 1993-01-13
AU7469091A (en) 1991-10-21
DE69116552D1 (de) 1996-02-29
GR3019018T3 (en) 1996-05-31
EP0521916B1 (en) 1996-01-17
HUT63062A (en) 1993-07-28
PT97082B (pt) 1998-07-31
JPH05505799A (ja) 1993-08-26
ATE133074T1 (de) 1996-02-15
DE69116552T2 (de) 1996-05-30
CA2078676A1 (en) 1991-09-22
CN1055116A (zh) 1991-10-09
IL97600A0 (en) 1992-06-21
ES2082201T3 (es) 1996-03-16
IE910921A1 (en) 1991-09-25
IE72204B1 (en) 1997-04-09
FI924215A (fi) 1992-09-21
MY108672A (en) 1996-10-31
WO1991014450A1 (en) 1991-10-03
DK0521916T3 (da) 1996-03-04
ZA912037B (en) 1992-03-25
OA09672A (en) 1993-05-15

Similar Documents

Publication Publication Date Title
IL87621A0 (en) Conjugates of cytokines with immunoglobulins,their preparation and pharmaceutical compositions containing them
YU48250B (sh) Postupak za pripremanje aktivne vakcine protiv lajmske bolesti
ATE157257T1 (de) Verstärkung der unterdrückungsregulation von autoimmunkrankheiten durch orale oder enterale verabreichung von autoantigenen
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
NO821832L (no) Fremgangsmaate for fremstilling av allergenholdige kapsler
DE69130071T2 (de) Zusammensetzung verwendbar als therapeutisches mittel gegen chronische virale leberkrankheiten
DE60040740D1 (de) VERWENDUNG OF INTERLEUkIN-1 MUTEIN ALS IMPFSTOFFADJUVANS
FI924215A0 (fi) Anvaendningen av il-4 foer oekning av immunreaktionen foerorsakad infektiosa antigen aemnen.
DE69129459T2 (de) Immunosuppressive zusammensetzungen
ATE67783T1 (de) Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
DK0563254T3 (da) Anvendelse af IL-4 til forstærkning af immunrespons på immunogener i vacciner
ATE93388T1 (de) Paracetamol enthaltende arzneizubereitung.
ATE229981T1 (de) Glykolisierte cytokine
KR960700741A (ko) 인터페론치료에 대한 무응답자의 c형 간염 치료방법(method of treating hepatitis c in non-pesponders to interferon treatment)
ATE385809T1 (de) Saponin-zusammensetzungen und deren verwendung
DE69706657D1 (de) Natürliches menschliches alpha interferon enthaltende pharmazeutische zusammensetzungen
FI981624A (fi) Koostumukset ja menetelmät Borrelia burgdorferi antigeenien annostelemiseksi
ATE64855T1 (de) Zubereitungen und verfahren zum schutz von tlymphozyten gegen das krankheitsagens von lymphadenopathie und vom erworbenen immundepressionsyndrom.
IT1276453B1 (it) Vaccino/composizioni terapautica di helycobacter pylori, loro preparazione ed impiego.

Legal Events

Date Code Title Description
FD Application lapsed